125 related articles for article (PubMed ID: 9222284)
41. Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands.
Blommestein HM; de Groot S; Aarts MJ; Vemer P; de Vries R; van Abeelen AF; Posthuma EF; Uyl-de Groot CA
Leuk Res; 2016 Nov; 50():37-45. PubMed ID: 27657652
[TBL] [Abstract][Full Text] [Related]
42. Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes.
Bank BB; Kanganis D; Liebes LF; Silber R
Cancer Res; 1989 Feb; 49(3):554-9. PubMed ID: 2910477
[TBL] [Abstract][Full Text] [Related]
43. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
[TBL] [Abstract][Full Text] [Related]
44. Comparison of infrared spectra of CLL cells with their ex vivo sensitivity (MTT assay) to chlorambucil and cladribine.
Liu KZ; Schultz CP; Johnston JB; Lee K; Mantsch HH
Leuk Res; 1997; 21(11-12):1125-33. PubMed ID: 9444947
[TBL] [Abstract][Full Text] [Related]
45. In vitro chemosensitivity testing in chronic lymphocytic leukaemia patients.
Hanson JA; Bentley DP; Bean EA; Nute SR; Moore JL
Leuk Res; 1991; 15(7):565-9. PubMed ID: 1861539
[TBL] [Abstract][Full Text] [Related]
46. Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisolone.
Drake WM; Monson JP; Trainer PJ; Sharief M; Dick JP; Kelsey SM
J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):564. PubMed ID: 9576561
[No Abstract] [Full Text] [Related]
47. The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemia.
Morabito F; Callea I; Console G; Stelitano C; Sculli G; Filangeri M; Oliva B; Musolino C; Iacopino P; Brugiatelli M
Haematologica; 1997; 82(5):560-5. PubMed ID: 9407721
[TBL] [Abstract][Full Text] [Related]
48. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
[TBL] [Abstract][Full Text] [Related]
49. Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells.
Pepper C; Hooper K; Thomas A; Hoy T; Bentley P
Leuk Lymphoma; 2001 Jul; 42(3):491-8. PubMed ID: 11699414
[TBL] [Abstract][Full Text] [Related]
50. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
51. Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia.
Tefferi A; Levitt R; Li CY; Schroeder G; Tschetter LK; Michalak JC; Krook JE; Witzig TE
Am J Clin Oncol; 1999 Oct; 22(5):509-16. PubMed ID: 10521069
[TBL] [Abstract][Full Text] [Related]
52. Effect of the synthetic glucocorticoid, deflazacort, on body growth, pulsatile secretion of GH and thymolysis in the rat.
Latta K; Krieg RJ; Hisano S; Veldhuis JD; Chan JC
Eur J Endocrinol; 1999 May; 140(5):441-6. PubMed ID: 10229911
[TBL] [Abstract][Full Text] [Related]
53. U.S. Food and drug administration approval: obinutuzumab in combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemia.
Lee HZ; Miller BW; Kwitkowski VE; Ricci S; DelValle P; Saber H; Grillo J; Bullock J; Florian J; Mehrotra N; Ko CW; Nie L; Shapiro M; Tolnay M; Kane RC; Kaminskas E; Justice R; Farrell AT; Pazdur R
Clin Cancer Res; 2014 Aug; 20(15):3902-7. PubMed ID: 24824310
[TBL] [Abstract][Full Text] [Related]
54. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial.
Hillmen P; Robak T; Janssens A; Babu KG; Kloczko J; Grosicki S; Doubek M; Panagiotidis P; Kimby E; Schuh A; Pettitt AR; Boyd T; Montillo M; Gupta IV; Wright O; Dixon I; Carey JL; Chang CN; Lisby S; McKeown A; Offner F;
Lancet; 2015 May; 385(9980):1873-83. PubMed ID: 25882396
[TBL] [Abstract][Full Text] [Related]
55. Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.
Knauf WU; Lissitchkov T; Aldaoud A; Liberati AM; Loscertales J; Herbrecht R; Juliusson G; Postner G; Gercheva L; Goranov S; Becker M; Fricke HJ; Huguet F; Del Giudice I; Klein P; Merkle K; Montillo M
Br J Haematol; 2012 Oct; 159(1):67-77. PubMed ID: 22861163
[TBL] [Abstract][Full Text] [Related]
56. DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia.
Müller MR; Buschfort C; Thomale J; Lensing C; Rajewsky MF; Seeber S
Clin Cancer Res; 1997 Nov; 3(11):2055-61. PubMed ID: 9815597
[TBL] [Abstract][Full Text] [Related]
57. Deflazacort in the treatment of haematologic disorders.
Gobbi M; Scudeletti M
Eur J Clin Pharmacol; 1993; 45 Suppl 1():S25-8. PubMed ID: 8313930
[TBL] [Abstract][Full Text] [Related]
58. Towards improved frontline treatment of CLL in the elderly.
Goede V; Hallek M
Lancet; 2015 May; 385(9980):1814-5. PubMed ID: 25882395
[No Abstract] [Full Text] [Related]
59. Secondary acute leukemia in chronic lymphocytic leukemia.
Grünwald HW; Rosner F
N Engl J Med; 1998 Sep; 339(13):924. PubMed ID: 9750094
[No Abstract] [Full Text] [Related]
60. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
